Pharmaceutical Research

, Volume 24, Issue 3, pp 593–604 | Cite as

Glycine Crystallization in Frozen and Freeze-dried Systems: Effect of pH and Buffer Concentration

  • Dushyant B. Varshney
  • Satyendra Kumar
  • Evgenyi Y. Shalaev
  • Prakash Sundaramurthi
  • Shin-Woong Kang
  • Larry A. Gatlin
  • Raj Suryanarayanan
Research Paper

Abstract

Purpose

(1) To determine the effect of solution pH before lyophilization, over the range of 1.5 to 10, on the salt and polymorphic forms of glycine crystallizing in frozen solutions and in lyophiles. (2) To quantify glycine crystallization during freezing and annealing as a function of solution pH before lyophilization. (3) To study the effect of phosphate buffer concentration on the extent of glycine crystallization before and after annealing.

Materials and Methods

Glycine solutions (10% w/v), with initial pH ranging from 1.5 to 10, were cooled to −50°C, and the crystallized glycine phases were identified using a laboratory X-ray source. Over the same pH range, glycine phases in lyophiles obtained from annealed solutions (0.25, 2 and 10% w/v glycine), were characterized by synchrotron X-ray diffractometry (SXRD). In the pH range of 3.0 to 5.9, the extent of glycine crystallization during annealing was monitored by SXRD. Additionally, the effect of phosphate buffer concentration (50 to 200 mM) on the extent of glycine crystallization during freezing, followed by annealing, was determined.

Results

In frozen solutions, β-glycine was detected when the initial solution pH was ≥ 4. In the lyophiles, in addition to β- and γ-glycine, glycine HCl, diglycine HCl, and sodium glycinate were also identified. In the pH range of 3.0 to 5.9, decreasing the pH reduced the extent of glycine crystallization in the frozen solution. When the initial pH was fixed at 7.4, and the buffer concentration was increased from 50 to 200 mM, the extent of glycine crystallization in frozen solutions decreased with an increase in buffer concentration.

Conclusion

Both solution pH and solute concentration before lyophilization influenced the salt and polymorphic forms of glycine crystallizing in frozen solutions and in lyophiles. The extent of glycine crystallization in frozen solutions was affected by the initial pH and buffer concentration of solutions. The high sensitivity of SXRD allowed simultaneous detection and quantification of multiple crystalline phases.

Key words

freeze-drying glycine lyophiles phosphate buffer polymorphs and salts synchrotron XRD 

References

  1. 1.
    M. J. Pikal. Freeze Drying. In J. Swarbrick and J.C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, 2002, pp. 1299–1326.Google Scholar
  2. 2.
    L. A. Trissel. Handbook of Injectable Drugs, ASHP, Bethesda, MD, 1994.Google Scholar
  3. 3.
    X. Tang and M. J. Pikal. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm. Res. 21:191–200 (2004).PubMedCrossRefGoogle Scholar
  4. 4.
    J. F. Carpenter, B. S. Chang, W. Garzon-Rodriguez, and T. W. Randolph. Rational design of stable lyophilized protein formulations: theory and practice. In J. F. Carpenter and M. C. Manning (eds.), Rational design of stable lyophilized protein formulations: theory and practice, Plenum, New York, 2002, pp. 109–133.Google Scholar
  5. 5.
    T. W. Randolph. Phase separation of excipients during lyophilization: effects on protein stability. J. Pharm. Sci. 86:1198–1202 (1997).PubMedCrossRefGoogle Scholar
  6. 6.
    E. Y. Shalaev, F. Franks, and P. Echlin. Crystalline and amorphous phases in the ternary system water–sucrose–sodium chloride. J. Phys. Chem. 100:1144–1152 (1996).CrossRefGoogle Scholar
  7. 7.
    E. Y. Shalaev. The impact of buffer on processing, and stability of freeze-dried dosage forms, part 1: solution freezing behavior. Amer. Pharm. Rev. 8:80–87 (2005).Google Scholar
  8. 8.
    J. F. Carpenter, M. J. Pikal, B. S. Chang, and T. W. Randolph. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res. 14:969–975 (1997).PubMedCrossRefGoogle Scholar
  9. 9.
    X. Li and S. L. Nail. Kinetics of glycine crystallization during freezing of sucrose/glycine excipient systems. J. Pharm. Sci. 94:625–631 (2005).PubMedCrossRefGoogle Scholar
  10. 10.
    K. Chatterjee, E. Y. Shalaev, and R. Suryanarayanan. Partially crystalline systems in lyophilization: I. Use of ternary state diagram to determine extent of crystallization of bulking agent. J. Pharm. Sci. 94:798–808 (2005).PubMedCrossRefGoogle Scholar
  11. 11.
    E. Y. Shalaev, D. V. Malakhov, A. N. Kanev, V. I. Kosyakov, F. V. Tuzikov, N. A. Varaksin, and V. J. Vavillin. Study of the phase diagram water fraction of the system water–glycine–sucrose by DTA and X-ray methods. Thermochim. Acta 196:210–220 (1992).CrossRefGoogle Scholar
  12. 12.
    A. Pyne, K. Chatterjee, and R. Suryanarayanan. Solute crystallization in mannitol–glycine systems—implications on protein stabilization in freeze-dried formulations. J. Pharm. Sci. 92:2272–2283 (2003).PubMedCrossRefGoogle Scholar
  13. 13.
    J. S. Searles, J. F. Carpenter, and T. W. Randolph. Annealing to optimize the primary drying rate, reduces freezing–induces drying rate heterogeneity, and determine Tg’ in pharmaceutical lyophilization. J. Pharm. Sci. 90:872–887 (2001).PubMedCrossRefGoogle Scholar
  14. 14.
    K. A. Pikal-Cleland, J. L. Cleland, T. J. Anchordoquy, and J. F. Carpenter. Effect of glycine on pH changes and protein stability during freezing–thawing in phosphate buffer systems. J. Pharm. Sci. 91:1969–1979 (2002).PubMedCrossRefGoogle Scholar
  15. 15.
    L. van den Berg. pH changes in buffers and foods during freezing and subsequent storage. Cryobiology 3:236–242 (1966).CrossRefGoogle Scholar
  16. 16.
    L. van den Berg and D. Rose. Effect of freezing on the pH and composition of sodium and potassium phosphate solutions: The reciprocal system: KH2PO4–Na2HPO4–H2O. Arch. Biochem. Biophys. 81:319–329 (1959).CrossRefGoogle Scholar
  17. 17.
    C. S. Towler, R. J. Davey, R. W. Lancaster, and C. J. Price. Impact of speciation on crystal nucleation in polymorphic systems: the conundrum of γ glycine and molecular ‘self poisoning’. J. Am. Chem. Soc. 126:13347–13353 (2004).PubMedCrossRefGoogle Scholar
  18. 18.
    I. Weissbuch, V. Y. Torbeev, L. Leiserwitz, and M. Lahav. Solvent effects on crystal polymorphism: why addition of methanol or ethanol to aqueous solutions induces the precipitation of the least stable β form of glycine. Angew. Chem., Int. Ed. 44:3226–3229 (2005).CrossRefGoogle Scholar
  19. 19.
    E. S. Ferrari, R. J. Davey, W. I. Cross, A. L. Gillon, and C. S. Towler. Crystallization in polymorphic systems: the solution-mediated transformation of β to α glycine. Cryst. Growth Des. 3:53–60 (2003).CrossRefGoogle Scholar
  20. 20.
    E. V. Boldyreva, V. A. Drebushchak, T. N. Drebushchak, I. E. Paukov, Y. A. Kovalevskaya, and E. S. Shutova. Polymorphism in glycine. Thermodynamic aspects. Part I. Relative stability of the polymorphs. J. Therm. Anal. Calorim. 73:409–418 (2003).CrossRefGoogle Scholar
  21. 21.
    H. Sakai, H. Hosogai, and T. Kawakita. Transformation of α-glycine to γ-glycine. J. Cryst. Growth 116:421–426 (1992).CrossRefGoogle Scholar
  22. 22.
    B. A. Garetz, J. Matic, and A. S. Myerson. Polarization switching of crystal structure in the nonphotochemical light-induced nucleation of supersaturated aqueous glycine solutions. Phys. Rev. Lett. 89:1755501-1-4 (2002).CrossRefGoogle Scholar
  23. 23.
    A. Ito, M. Yamanobe-Hada, and H. Shindo. In situ AFM observation of polymorphic transformation at crystal surface of glycine. J. Cryst. Growth 275:e1691–e1995 (2005).CrossRefGoogle Scholar
  24. 24.
    G. L. Perlovich, L. K. Hansen, and A. Bauer-Brand. The polymorphism of glycine. Thermochemical and structural aspects. J. Therm. Anal. Calorim. 66:699–715 (2001).CrossRefGoogle Scholar
  25. 25.
    E. S. Ferrari, R. J. Davey, W. I. Cross, A. I. Gillon, and C. S. Towler. Crystallization in polymorphic systems: the solution-mediated transformation of β to α glycine. Cryst. Growth. Des. 3:53–60 (2003).CrossRefGoogle Scholar
  26. 26.
    T. D. Davis, G. E. Peck, J. G. Stowel, K. R. Morris, and S. R. Byrn. Modeling and monitoring of polymorphic transformations during the drying phase of wet granulation. Pharm. Res. 21:860–866 (2004).PubMedCrossRefGoogle Scholar
  27. 27.
    L. Yu and K. Ng. Glycine crystallization during spray drying: the pH effect on salt and polymorphic forms. J. Pharm. Sci. 91:2367–2375 (2002).PubMedCrossRefGoogle Scholar
  28. 28.
    M. J. Akers, N. Milton, S. R. Byrn, and S. L. Nail. Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength. Pharm. Res. 12:1457–1461 (1995).PubMedCrossRefGoogle Scholar
  29. 29.
    S. Chongprasert, S. A. Knopp, and S. L. Nail. Characterization of frozen solutions of glycine. J. Pharm. Sci. 90:1720–1728 (2001).PubMedCrossRefGoogle Scholar
  30. 30.
    A. Pyne and R. Suryanarayanan. Phase transitions of glycine in frozen aqueous solutions and during freeze-drying. Pharm. Res. 18:1448–1454 (2001).PubMedCrossRefGoogle Scholar
  31. 31.
    G. Gomez, M. J. Pikal, and N. Rodriguez-Hornedo. Effect of initial buffer composition on pH changes during far-from equilibrium freezing of sodium phosphate buffer solutions. Pharm. Res. 18:90–97 (2001).PubMedCrossRefGoogle Scholar
  32. 32.
    G. Gomez. Crystallization-related pH changes during freezing of sodium phosphate buffer solutions, Ph.D. Dissertation, University of Michigan, Ann Arbor, Michigan, 1995.Google Scholar
  33. 33.
    D. B. Varshney, S. Kumar, E. Y. Shalaev, S. W. Kang, L. A. Gatlin, and R. Suryanarayanan. Solute crystallization in frozen systems—use of synchrotron radiation to improve sensitivity. Pharm Res. 46:41–47 (2006).Google Scholar
  34. 34.
    R. Govindarajan, K. Chatterjee, L. Gatlin, R. Suryanarayanan, and E. Y. Shalaev. Impact of freeze-drying on ionization of sulfonephthalein probe molecules in trehalose–citrate systems. J. Pharm. Sci. 95:1498–1510 (2006).PubMedCrossRefGoogle Scholar
  35. 35.
    N. Blagden, R. Davey, M. Song, M. Quayle, S. Clark, D. Taylor, and A. Nield. A novel batch cooling crystallization for in situ monitoring of solution crystallization using energy dispersive X-ray diffraction. Cryst. Growth Des. 3:197–201 (2003).CrossRefGoogle Scholar
  36. 36.
    C. Nunes. Use of High-Intensity X-Radiation in Solid-State Characterization of Pharmaceuticals, Ph.D. Dissertation, Department of Pharmaceutics, University of Minnesota, 2005.Google Scholar
  37. 37.
    C. Nunes, A. Mahendrasingam, and R. Suryanarayanan. Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry. Pharm. Res. 22:1942–1953 (2005).PubMedCrossRefGoogle Scholar
  38. 38.
    A. P. Hammersley. ESRF internal report, ESRF97HA02T, “Fit2D: an introduction and overview”, (1997).Google Scholar
  39. 39.
    A. P. Hammersley, S. O. Svensson, M. Hanfland, A. N. Fitch, and D. Häusermann. Two-dimensional detector software: from real detector to idealized image or two-theta scan. High Press. Res. 14:235–248 (1996).CrossRefGoogle Scholar
  40. 40.
    Powder Diffraction File. (hexagonal ice, PDF-2, Card #00-042-1142), International Centre for Diffraction Data, Newtown Square, PA, 1996.Google Scholar
  41. 41.
    Powder Diffraction File. (disodium hydrogen phosphate dodecahydrate, PDF-2, Card #00-011-0657), International Centre for Diffraction Data, Newtown Square, PA, 1996.Google Scholar
  42. 42.
    Powder Diffraction File. (glycine polymorphs and salts, α-glycine (+H3NCH2CO2 ), PDF-2, Card #00-32-1702; β-glycine (+H3NCH2CO2 ), PDF-2, Card #00-002-0171; γ-glycine (+H3NCH2CO2 ) PDF-2, Card #00-006-0230; glycine hydrochloride (+H3NCH2CO2H·Cl), PDF-2, Card #00-022-1744; diglycine hydrochloride (+H3NCH2CO2 ·+H3NCH2CO2H·Cl-), PDF-2, Card #00-032-1649), International Centre for Diffraction Data, Newtown Square, PA, 1996.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Dushyant B. Varshney
    • 1
    • 2
  • Satyendra Kumar
    • 3
  • Evgenyi Y. Shalaev
    • 4
  • Prakash Sundaramurthi
    • 1
  • Shin-Woong Kang
    • 5
  • Larry A. Gatlin
    • 4
  • Raj Suryanarayanan
    • 1
  1. 1.Department of Pharmaceutics, College of PharmacyUniversity of MinnesotaMinneapolisUSA
  2. 2.Eli Lilly and CompanyLilly Corporate CenterIndianapolisUSA
  3. 3.Division for Materials ResearchNational Science FoundationArlingtonUSA
  4. 4.Pfizer Groton LaboratoriesGrotonUSA
  5. 5.Department of PhysicsKent State UniversityKentUSA

Personalised recommendations